Delivery Order SPE2DB22D3009-SPE2DB24FBB56
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FPD76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,463.71, is for the delivery of 60 tablets of the medication Naltrexone 50 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of January 21, 2025. The contract does not have a set-aside designation,...
The federal contract award SPE2DB22D1106|SPE2DB25FDJR7, with a ceiling value of $2,374.86, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of 60 tablet packages of Naltrexone 50 mg. The contract has a firm fixed-price pricing type and an ultimate completion date of November 1, 2024. This award is...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDKL8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,176.13 firm fixed-price delivery order is for the supply of 4566357761 - Naltrexone 50 mg tablets in quantities of 60s. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D3101|SPE2DB22FJ4N3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naltrexone 50 mg tablets. The $1,546.46 firm-fixed-price delivery order represents a portion of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award, valued at $31,508.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of Naltrexone 50 mg tablets to support military healthcare programs. This pharmaceutical product is used in the treatment of opioid and alcohol dependence. The contract has...
This federal contract award, SPE2DB20D3505|SPE2DB25FT9E7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,118,963 units of Naltrexone 50 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,813.91 and a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,362.28, is for the delivery of Naltrexone 50 mg tablets in 60-count packaging. It is a firm fixed-price delivery order with a performance period ending on May 6, 2025. The contract is not set aside and was awarded on May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,972.91, is for the delivery of 100 units of Naltrexone 50 mg tablets. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,205.96, is for the delivery of Naltrexone 50 mg tablets. This is a firm fixed-price delivery order contract that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHX38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,283.91, is for the delivery of Naltrexone 50 mg tablets, a medication used in the treatment of opioid and alcohol dependence. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...